Business Wire

Fujitsu Delivers New Family of UHF RFID Tags for Linens, Fashion Apparel and Accessories for European Markets


Fujitsu Frontech North America Inc., a leader in innovative technology and front-end solutions has announced today that it is now shipping its new Ultra-High Frequency (UHF) RFID tags for industrial garments and flat linens as well as their new Fashion tag for formal wear, high fashion apparel, garments, and accessories. The new Fujitsu WT-A522L and WT-A522LA Fashion tags, which are about the size of a typical shirt collar stay, are virtually imperceptible when installed in the sheerest of garments. For industrial applications, Fujitsu is introducing the new, ultra-rugged, WT-A533 tag for industrial linen processes. Fujitsu will be showing the new family of washable RFID tags at Texcare International on June 11 thru 15 2016 at the Frankfurt am Main convention center in Hall 8 Level 0 Booth A65.

Unlike most garment RFID tags, this new WT-A522L Fashion tag is made from transparent materials and is virtually invisible when sewn into clothing or accessories. From fine silks and lace to sheer gowns, the new Fashion tag provides Fashion Designers and Retailers protection against counterfeiting and fraud. Fashion apparel and formal wear rental enterprises will also benefit by providing precise tracking of rental garments and accessories at the item level, without having to unbox and individually read a bar code. The new Fujitsu Fashion tag is designed for permanent installation into fashion apparel, suits, formal wear, and jeans. Measuring only 55mm x 10mm x 0.3 mm, the WT-A522L tag can easily be sewn into hems, seams, or under manufacturers’ labels and is home wash, dry-clean, and ironing safe. Fujitsu will also offer the WT-A522LA with a strong adhesive for attachment to shoes, handbags, and accessories.

For industrial garment and linen applications, Fujitsu is announcing the new WT-A533 Linen tag for heavy-duty industrial laundry applications. The new Linen tag has an advanced mechanical design which gives it extra strength and reliability in heavy-duty industrial garment and flat linen applications. Customers will have the ability to perform bulk reading of hundreds, even thousands, of articles simultaneously in seconds with very high reliability and reading density. Bulk reading enables streamlined automated processes and significant reductions in labor costs compared to HF systems which require single or small quantity processing. The WT-A533 tag is the same size and has the same soft exterior as its predecessor, the WT-A522, but has increased reading range and rugged durability.

“UHF RFID technology will significantly reduce the labor cost compared to single garment processing at tuxedo and high fashion rental companies. Also, fraud and counterfeiting in high fashion apparel is on the rise. Including an ‘invisible’ RFID tag in high-value garments and accessories will provide positive confirmation of an item’s authenticity and also help reduce incidents of fraud”, said Randy Fox, Vice President of Sales and Marketing, Fujitsu Frontech North America Inc. “The WT-A533 Linen tag and the WT-A522L Fashion tags provide any garment manufacturer, rental or laundry operation one-stop shopping for all of their RFID needs”.

About Fujitsu

Fujitsu is the leading Japanese information and communication technology (ICT) company, offering a full range of technology products, solutions and services. Approximately 159,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE: 6702) reported consolidated revenues of 4.8 trillion yen (US$40 billion) for the fiscal year ended March 31, 2015. For more information, please see

About Fujitsu Frontech North America Inc.

Fujitsu Frontech North America Inc. (FFNA) provides market-focused IT solutions that enable customers to achieve their business objectives through integrated offerings for self-checkout and currency management solutions, kiosks, mobile, RFID, and biometric authentication technology. FFNA delivers industry-specific solutions for the manufacturing, retail, healthcare, government, education, financial services, and enterprise and communications sectors throughout North America. FFNA is headquartered with operations and product development at 27121 Towne Centre Drive, Foothill Ranch, CA 92610.

Copyright 2016 Fujitsu Frontech North America Inc. All rights reserved. Fujitsu and the Fujitsu logo are registered trademarks. All other trademarks are the property of their respective owners. Statements herein are based on normal operating conditions and are not intended to create any implied warranty of merchantability or fitness for a particular purpose. Fujitsu Frontech North America Inc. reserves the right to modify at any time without notice these statements, their services, products, and their warranty and performance specifications.

Contact information

Fujitsu Frontech North America Inc.
Dan Dalton, +1-949-855-5590

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on